The cholesterol transporter ABCA9, which accumulates cholesterol in the endoplasmic reticulum (ER), reduces SREBP2 expression, thereby impairing breast cancer cell proliferation (Hwang et al., 2023). Here, SREBF2 is linked to breast cancer.